Prokinetic therapy for gastroenterological diseases
暂无分享,去创建一个
[1] A. Zinsmeister,et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility , 1991, Digestive Diseases and Sciences.
[2] M. Lefkowitz,et al. Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms. , 2002 .
[3] C. Beglinger,et al. Tegaserod, a 5‐HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects , 2001, Alimentary pharmacology & therapeutics.
[4] F. Pace,et al. Tegaserod, a 5‐HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation , 2001, Alimentary pharmacology & therapeutics.
[5] N. Talley. Therapeutic Options in Nonulcer Dyspepsia , 2001, Journal of clinical gastroenterology.
[6] M. Mirmiran,et al. Cisapride Decreases Gastroesophageal Reflux in Preterm Infants , 2001, Pediatrics.
[7] M. Camilleri. Review article: tegaserod. , 2001, Alimentary pharmacology & therapeutics.
[8] A. Zinsmeister,et al. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. , 2001, Gastroenterology.
[9] E. Christensen,et al. Which dyspepsia patients will benefit from omeprazole treatment?: Analysis of a Danish multicenter trial , 2000 .
[10] A. Zinsmeister,et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. , 2000, Gastroenterology.
[11] V. Khoshoo,et al. Effect of cisapride on the QT interval in infants with gastroesophageal reflux. , 2000, Pediatrics.
[12] M. Camilleri,et al. Functional gastroduodenal disorders , 1999, Gut.
[13] A. Berstad,et al. Heartburn treatment in primary care: randomised, double blind study for 8 weeks , 1999, BMJ.
[14] D. Patterson,et al. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesisFig. 1 , 1999, American Journal of Gastroenterology.
[15] E. O'Loughlin,et al. Cisapride in the control of symptoms in infants with gastroesophageal reflux: A randomized, double-blind, placebo-controlled trial. , 1999, The Journal of pediatrics.
[16] M. Kimmey,et al. Neostigmine for the treatment of acute colonic pseudo-obstruction. , 1998, The New England journal of medicine.
[17] G. Boeckxstaens,et al. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. , 1998, Gastroenterology.
[18] J. Tack,et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. , 1998, Gastroenterology.
[19] G. Boeckxstaens,et al. Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension. , 1998 .
[20] M. Hughes,et al. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. , 1998, Journal of clinical gastroenterology.
[21] M. Samsom,et al. Responses to gastric distension in functional dyspepsia , 1998, Gut.
[22] R. Scott,et al. Cisapride in pediatric gastroesophageal reflux. , 1997, Journal of pediatric gastroenterology and nutrition.
[23] F. Turégano-Fuentes,et al. Early resolution of Ogilvie's syndrome with intravenous neostigmine , 1997, Diseases of the colon and rectum.
[24] É. Bellissant,et al. The triangular test to assess the efficacy of metoclopramide in gastroesophageal reflux , 1997, Clinical pharmacology and therapeutics.
[25] R. Giusti,et al. Chronic Administration of Levosulpiride and Glycemic Control in IDDM Patients With Gastroparesis , 1997, Diabetes Care.
[26] J. Dent,et al. Esophageal body and lower esophageal sphincter function in healthy premature infants. , 1995, Gastroenterology.
[27] A. Pilotto,et al. A comparison of five maintenance therapies for reflux esophagitis. , 1995, The New England journal of medicine.
[28] J. Galmiche,et al. Erythromycin enhances fasting and postprandial proximal gastric tone in humans. , 1995, Gastroenterology.
[29] M. Wheeler,et al. Ogilvie's syndrome: A new approach to an old problem , 1995, Diseases of the colon and rectum.
[30] M. Camilleri. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. , 1994, The American journal of gastroenterology.
[31] A. Zinsmeister,et al. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. , 1994, Gastroenterology.
[32] M. Soresi,et al. Domperidone plus magnesium hydroxide and aluminum hydroxide: a valid therapy in children with gastroesophageal reflux. A double-blind randomized study versus placebo. , 1994, Scandinavian journal of gastroenterology.
[33] M. Camilleri. The current role of erythromycin in the clinical management of gastric emptying disorders. , 1993, The American journal of gastroenterology.
[34] J. Gooris,et al. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study. , 1993, Scandinavian journal of gastroenterology. Supplement.
[35] C. Griffiths,et al. Acute colonic pseudo-obstruction: a pharmacological approach. , 1992, Annals of the Royal College of Surgeons of England.
[36] S. Treves,et al. Efficacy of Domperidone in Infants and Children with Gastroesophageal Reflux , 1992, Journal of pediatric gastroenterology and nutrition.
[37] P. Fairclough,et al. Erythromycin and the gut. , 1992, Gut.
[38] W. Hasler,et al. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. , 1991, The New England journal of medicine.
[39] M. Bonacini,et al. Erythromycin as therapy for acute colonic pseudo-obstruction (Ogilvie's syndrome) , 1991, Journal of clinical gastroenterology.
[40] B. Amor,et al. The effect of cisapride on gastro-oesophageal dysfunction in systemic sclerosis: a controlled manometric study. , 1991, British journal of clinical pharmacology.
[41] M. Bonacini. Pancreatic involvement in human immunodeficiency virus infection. , 1991, Journal of clinical gastroenterology.
[42] Y. Vandenplas,et al. Cisapride Decreases Prolonged Episodes of Reflux in Infants , 1991, Journal of pediatric gastroenterology and nutrition.
[43] K. Maccannell,et al. Treatment of acute colonic pseudoobstruction (Ogilvie's syndrome) with cisapride. , 1990, Gastroenterology.
[44] M. Feldman,et al. Effect of cisapride on gastric emptying of indigestible solids in patients with gastroparesis diabeticorum: A comparison with metoclopramide and placebo , 1987 .
[45] D. Orenstein,et al. Bethanechol for Pediatric Gastroesophageal Reflux: A Prospective, Blind, Controlled Study , 1986, Journal of pediatric gastroenterology and nutrition.
[46] J. Sondheimer,et al. Early Effects of Bethanechol on the Esophageal Motor Function of Infants with Gastroesophageal Reflux , 1986, Journal of pediatric gastroenterology and nutrition.
[47] W. P. Winkler,et al. Metoclopramide in the treatment of gastric bezoars. , 1983, The American journal of gastroenterology.
[48] J. Malagelada,et al. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. , 1980, Gastroenterology.